Childhood conduct disorder trajectories, prior risk factors and cannabis use at age 16: birth cohort study.

PubWeight™: 1.56‹?› | Rank: Top 4%

🔗 View Article (PMC 3908358)

Published in Addiction on July 12, 2013

Authors

Jon Heron1, Edward D Barker, Carol Joinson, Glyn Lewis, Matthew Hickman, Marcus Munafò, John Macleod

Author Affiliations

1: School of Social and Community Medicine, University of Bristol, Bristol, UK.

Articles citing this

Clinical and social outcomes of adolescent self harm: population based birth cohort study. BMJ (2014) 2.24

Are IQ and educational outcomes in teenagers related to their cannabis use? A prospective cohort study. J Psychopharmacol (2016) 0.90

The association between speed of transition from initiation to subsequent use of cannabis and later problematic cannabis use, abuse and dependence. Addiction (2015) 0.82

Effectiveness of a Web-Based Screening and Fully Automated Brief Motivational Intervention for Adolescent Substance Use: A Randomized Controlled Trial. J Med Internet Res (2016) 0.80

Comparison of cannabinoids in hair with self-reported cannabis consumption in heavy, light and non-cannabis users. Drug Alcohol Rev (2016) 0.79

Moderate alcohol drinking in pregnancy increases risk for children's persistent conduct problems: causal effects in a Mendelian randomisation study. J Child Psychol Psychiatry (2015) 0.77

EARLY LIFE RISKS, ANTISOCIAL TENDENCIES, AND PRETEEN DELINQUENCY. Criminology (2015) 0.75

Commentary on Heron et al. (2013): Findings on associations between conduct problem trajectories, early risk factors and adolescent cannabis use-how do they fit with existing theories? Addiction (2013) 0.75

Adolescent cannabis use, change in neurocognitive function, and high-school graduation: A longitudinal study from early adolescence to young adulthood. Dev Psychopathol (2016) 0.75

Marijuana Use, Recent Marijuana Initiation, and Progression to Marijuana Use Disorder Among Young Male and Female Adolescents Aged 12-14 Living in US Households. Subst Abuse (2017) 0.75

Articles cited by this

Detection of postnatal depression. Development of the 10-item Edinburgh Postnatal Depression Scale. Br J Psychiatry (1987) 32.05

Multiple imputation of missing blood pressure covariates in survival analysis. Stat Med (1999) 18.50

Psychometric properties of the strengths and difficulties questionnaire. J Am Acad Child Adolesc Psychiatry (2001) 15.43

ALSPAC--the Avon Longitudinal Study of Parents and Children. I. Study methodology. Paediatr Perinat Epidemiol (2001) 14.31

Use and misuse of population attributable fractions. Am J Public Health (1998) 12.96

Cohort Profile: the 'children of the 90s'--the index offspring of the Avon Longitudinal Study of Parents and Children. Int J Epidemiol (2012) 11.79

Cohort Profile: the Avon Longitudinal Study of Parents and Children: ALSPAC mothers cohort. Int J Epidemiol (2012) 6.91

Comparing the Strengths and Difficulties Questionnaire and the Child Behavior Checklist: is small beautiful? J Abnorm Child Psychol (1999) 5.26

How independent are "independent" effects? Relative risk estimation when correlated exposures are measured imprecisely. J Clin Epidemiol (1991) 3.37

Childhood externalizing and internalizing psychopathology in the prediction of early substance use. Addiction (2004) 3.35

Female and male antisocial trajectories: from childhood origins to adult outcomes. Dev Psychopathol (2008) 3.07

The genetic epidemiology of cannabis use, abuse and dependence. Addiction (2006) 2.93

Conduct and attentional problems in childhood and adolescence and later substance use, abuse and dependence: results of a 25-year longitudinal study. Drug Alcohol Depend (2007) 2.69

Genetic and environmental contributions to cannabis dependence in a national young adult twin sample. Psychol Med (2002) 2.04

Tests of causal linkages between cannabis use and psychotic symptoms. Addiction (2005) 2.02

Effects of age at first substance use and psychiatric comorbidity on the development of substance use disorders. Drug Alcohol Depend (2004) 1.84

Synthesis of qualitative research on drug use in the European Union: report on an EMCDDA project. European Monitoring Centre for Drugs and Drug Addiction. Eur Addict Res (1999) 1.75

Cannabis use and cannabis use disorders and their relationship to mental disorders: a 10-year prospective-longitudinal community study in adolescents. Drug Alcohol Depend (2007) 1.71

Adolescent alcohol and tobacco use and early socioeconomic position: the ALSPAC birth cohort. Pediatrics (2011) 1.60

Differentiating early-onset persistent versus childhood-limited conduct problem youth. Am J Psychiatry (2009) 1.50

Early childhood predictors of early substance use and substance use disorders: prospective study. Aust N Z J Psychiatry (2008) 1.32

Role of individual, peer and family factors in the use of cannabis and other illicit drugs: a longitudinal analysis among Finnish adolescent twins. Drug Alcohol Depend (2008) 1.31

Conduct problems and early cannabis initiation: a longitudinal study of gender differences. Addiction (2001) 1.27

Parental drug use, early adversities, later childhood problems and children's use of tobacco and alcohol at age 10: birth cohort study. Addiction (2008) 1.14

Short scales to assess cannabis-related problems: a review of psychometric properties. Subst Abuse Treat Prev Policy (2008) 1.09

Patterns of alcohol use in early adolescence predict problem use at age 16. Alcohol Alcohol (2012) 1.02

The genetic aetiology of cannabis use initiation: a meta-analysis of genome-wide association studies and a SNP-based heritability estimation. Addict Biol (2012) 1.01

Predicting substance use in early adolescence based on parent and teacher assessments of childhood psychiatric disorder: results from the Ontario Child Health Study follow-up. J Child Psychol Psychiatry (1993) 0.98

Reporting bias and self-reported drug use. Addiction (2005) 0.94

Disruptive symptoms in childhood and adolescence and early initiation of tobacco and cannabis use: the Gazel Youth study. Eur Psychiatry (2010) 0.90

Association of maternal smoking and alcohol consumption with young adults' cannabis use: a prospective study. Am J Epidemiol (2007) 0.84

Articles by these authors

Cohort Profile: the 'children of the 90s'--the index offspring of the Avon Longitudinal Study of Parents and Children. Int J Epidemiol (2012) 11.79

Global epidemiology of injecting drug use and HIV among people who inject drugs: a systematic review. Lancet (2008) 11.44

Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review. Lancet (2007) 11.27

HIV prevention, treatment, and care services for people who inject drugs: a systematic review of global, regional, and national coverage. Lancet (2010) 8.02

Cohort Profile: the Avon Longitudinal Study of Parents and Children: ALSPAC mothers cohort. Int J Epidemiol (2012) 6.91

A mega-analysis of genome-wide association studies for major depressive disorder. Mol Psychiatry (2012) 6.34

Cognitive behavioural therapy as an adjunct to pharmacotherapy for primary care based patients with treatment resistant depression: results of the CoBalT randomised controlled trial. Lancet (2012) 5.61

Facilitated physical activity as a treatment for depressed adults: randomised controlled trial. BMJ (2012) 5.61

Global overview of injecting drug use and HIV infection among injecting drug users. AIDS (2004) 5.45

How ideology shapes the evidence and the policy: what do we know about cannabis use and what should we do? Addiction (2010) 5.08

Socioeconomic status and smoking: a review. Ann N Y Acad Sci (2011) 4.11

Risk of death during and after opiate substitution treatment in primary care: prospective observational study in UK General Practice Research Database. BMJ (2010) 4.09

Therapist-delivered Internet psychotherapy for depression in primary care: a randomised controlled trial. Lancet (2009) 3.90

Gene X environment interactions at the serotonin transporter locus. Biol Psychiatry (2008) 3.80

Randomised controlled trials investigating pharmacological and psychological interventions for treatment-refractory depression. Systematic review. Br J Psychiatry (2002) 3.72

Survival and cessation in injecting drug users: prospective observational study of outcomes and effect of opiate substitution treatment. BMJ (2010) 3.59

Opiate substitution treatment and HIV transmission in people who inject drugs: systematic review and meta-analysis. BMJ (2012) 3.46

Does alcohol increase the risk of overdose death: the need for a translational approach. Addiction (2008) 3.39

Addressing liver disease in the UK: a blueprint for attaining excellence in health care and reducing premature mortality from lifestyle issues of excess consumption of alcohol, obesity, and viral hepatitis. Lancet (2014) 3.12

Sleep duration and mortality: The effect of short or long sleep duration on cardiovascular and all-cause mortality in working men and women. Sleep Med (2002) 3.06

Treatment of postnatal depression in low-income mothers in primary-care clinics in Santiago, Chile: a randomised controlled trial. Lancet (2007) 3.03

Admissions for myocardial infarction and World Cup football: database survey. BMJ (2002) 2.99

The impact of needle and syringe provision and opiate substitution therapy on the incidence of hepatitis C virus in injecting drug users: pooling of UK evidence. Addiction (2011) 2.95

Deep impact: unintended consequences of journal rank. Front Hum Neurosci (2013) 2.78

Hepatitis C virus treatment for prevention among people who inject drugs: Modeling treatment scale-up in the age of direct-acting antivirals. Hepatology (2013) 2.76

Self reported cannabis use as a risk factor for schizophrenia in Swedish conscripts of 1969: historical cohort study. BMJ (2002) 2.74

A longitudinal study of premorbid IQ Score and risk of developing schizophrenia, bipolar disorder, severe depression, and other nonaffective psychoses. Arch Gen Psychiatry (2004) 2.65

Evidence for the effectiveness of sterile injecting equipment provision in preventing hepatitis C and human immunodeficiency virus transmission among injecting drug users: a review of reviews. Addiction (2010) 2.59

Resuscitation at birth and cognition at 8 years of age: a cohort study. Lancet (2009) 2.57

Meningococcal carriage by age: a systematic review and meta-analysis. Lancet Infect Dis (2010) 2.56

Methods to recruit hard-to-reach groups: comparing two chain referral sampling methods of recruiting injecting drug users across nine studies in Russia and Estonia. J Urban Health (2006) 2.52

Prevalence of HIV, hepatitis C and syphilis among injecting drug users in Russia: a multi-city study. Addiction (2006) 2.46

Violence against women by their intimate partner during pregnancy and postnatal depression: a prospective cohort study. Lancet (2010) 2.46

Can needle and syringe programmes and opiate substitution therapy achieve substantial reductions in hepatitis C virus prevalence? Model projections for different epidemic settings. Addiction (2012) 2.45

Detection of depression and anxiety in primary care: follow up study. BMJ (2002) 2.44

Explosive spread and high prevalence of HIV infection among injecting drug users in Togliatti City, Russia. AIDS (2002) 2.40

Paternal age and risk for schizophrenia. Br J Psychiatry (2003) 2.34

A qualitative study exploring how GPs decide to prescribe antidepressants. Br J Gen Pract (2005) 2.31

Paternal age and schizophrenia: a population based cohort study. BMJ (2004) 2.27

If cannabis caused schizophrenia--how many cannabis users may need to be prevented in order to prevent one case of schizophrenia? England and Wales calculations. Addiction (2009) 2.25

Examining interactions between risk factors for psychosis. Br J Psychiatry (2010) 2.25

DataSHIELD: resolving a conflict in contemporary bioscience--performing a pooled analysis of individual-level data without sharing the data. Int J Epidemiol (2010) 2.23

Family history of nocturnal enuresis and urinary incontinence: results from a large epidemiological study. J Urol (2011) 2.22

Cannabis and schizophrenia: model projections of the impact of the rise in cannabis use on historical and future trends in schizophrenia in England and Wales. Addiction (2007) 2.20

Psychotic experiences and psychotic disorders at age 18 in relation to psychotic experiences at age 12 in a longitudinal population-based cohort study. Am J Psychiatry (2013) 2.17

Fetal growth and childhood behavioral problems: results from the ALSPAC cohort. Am J Epidemiol (2006) 2.09

Inequalities in the uptake of human papillomavirus vaccination: a systematic review and meta-analysis. Int J Epidemiol (2013) 2.08

Public injecting and the need for 'safer environment interventions' in the reduction of drug-related harm. Addiction (2006) 2.06

Classroom based cognitive behavioural therapy in reducing symptoms of depression in high risk adolescents: pragmatic cluster randomised controlled trial. BMJ (2012) 2.05

Incidence of hepatitis C virus and HIV among new injecting drug users in London: prospective cohort study. BMJ (2004) 2.03

Drug-related mortality and its impact on adult mortality in eight European countries. Eur J Public Health (2005) 2.01

Enhanced detection and typing of human papillomavirus (HPV) DNA in anogenital samples with PGMY primers and the Linear array HPV genotyping test. J Clin Microbiol (2006) 1.96

Access and coverage of needle and syringe programmes (NSP) in Central and Eastern Europe and Central Asia. Addiction (2007) 1.95

HAART and progression to high-grade anal intraepithelial neoplasia in men who have sex with men and are infected with HIV. Clin Infect Dis (2011) 1.95

Violence and psychiatric morbidity in a national household population--a report from the British Household Survey. Am J Epidemiol (2006) 1.94

Introducing vaccination against serogroup B meningococcal disease: an economic and mathematical modelling study of potential impact. Vaccine (2013) 1.94

Obsessive-compulsive disorder: prevalence, comorbidity, impact, and help-seeking in the British National Psychiatric Morbidity Survey of 2000. Am J Psychiatry (2006) 1.93

Self-help books for depression: how can practitioners and patients make the right choice? Br J Gen Pract (2005) 1.91

Assessing IDU prevalence and health consequences (HCV, overdose and drug-related mortality) in a primary care trust: implications for public health action. J Public Health (Oxf) (2009) 1.89

Prevalence, clearance, and incidence of anal human papillomavirus infection in HIV-infected men: the HIPVIRG cohort study. J Infect Dis (2009) 1.89

Antiretroviral treatment for injecting drug users in developing and transitional countries 1 year before the end of the "Treating 3 million by 2005. Making it happen. The WHO strategy" ("3 by 5"). Addiction (2006) 1.87

Evaluation of a modified commercial assay in detecting antibody to hepatitis C virus in oral fluids and dried blood spots. J Med Virol (2003) 1.84

Stigma revisited, disclosure of emotional problems in primary care consultations in Wales. Soc Sci Med (2003) 1.84

Mothers' anxiety during pregnancy is associated with asthma in their children. J Allergy Clin Immunol (2009) 1.82

Prospective study of peer victimization in childhood and psychotic symptoms in a nonclinical population at age 12 years. Arch Gen Psychiatry (2009) 1.81

Risk of fatal overdose during and after specialist drug treatment: the VEdeTTE study, a national multi-site prospective cohort study. Addiction (2007) 1.81

The patient-doctor relationship: a synthesis of the qualitative literature on patients' perspectives. Br J Gen Pract (2009) 1.80

Association between availability of heroin and methadone and fatal poisoning in England and Wales 1993-2004. Int J Epidemiol (2006) 1.78

Opportunistic and systematic screening for chlamydia: a study of consultations by young adults in general practice. Br J Gen Pract (2006) 1.75

Contribution of common genetic variants to antidepressant response. Biol Psychiatry (2012) 1.73

Psychosis, victimisation and childhood disadvantage: evidence from the second British National Survey of Psychiatric Morbidity. Br J Psychiatry (2004) 1.72

Negative self-schemas and the onset of depression in women: longitudinal study. Br J Psychiatry (2005) 1.69

Cost-effectiveness of hepatitis C virus antiviral treatment for injection drug user populations. Hepatology (2011) 1.67

Parental socioeconomic status and risk of offspring autism spectrum disorders in a Swedish population-based study. J Am Acad Child Adolesc Psychiatry (2012) 1.65

IQ and non-clinical psychotic symptoms in 12-year-olds: results from the ALSPAC birth cohort. Br J Psychiatry (2008) 1.64

Alcohol consumption as a risk factor for anxiety and depression: results from the longitudinal follow-up of the National Psychiatric Morbidity Survey. Br J Psychiatry (2005) 1.63

Genetic variation at CHRNA5-CHRNA3-CHRNB4 interacts with smoking status to influence body mass index. Int J Epidemiol (2011) 1.61

Adolescent alcohol and tobacco use and early socioeconomic position: the ALSPAC birth cohort. Pediatrics (2011) 1.60

Comparative performance of culture using swabs transported in Amies medium and the Aptima Combo 2 nucleic acid amplification test in detection of Neisseria gonorrhoeae from genital and extra-genital sites: a retrospective study. Sex Transm Infect (2011) 1.58

Estimating long-term trends in the incidence and prevalence of opiate use/injecting drug use and the number of former users: back-calculation methods and opiate overdose deaths. Am J Epidemiol (2004) 1.57

Clinical effectiveness of collaborative care for depression in UK primary care (CADET): cluster randomised controlled trial. BMJ (2013) 1.56

The association between early autistic traits and psychotic experiences in adolescence. Schizophr Res (2012) 1.55

An early evaluation of clinical and economic costs and benefits of implementing point of care NAAT tests for Chlamydia trachomatis and Neisseria gonorrhoea in genitourinary medicine clinics in England. Sex Transm Infect (2013) 1.55

Partner notification of chlamydia infection in primary care: randomised controlled trial and analysis of resource use. BMJ (2005) 1.55

Epilepsy and psychiatric comorbidity: a nationally representative population-based study. Epilepsia (2012) 1.54

Self-reported psychotic symptoms in the general population: results from the longitudinal study of the British National Psychiatric Morbidity Survey. Br J Psychiatry (2006) 1.54

Effects of cannabis use on outcomes of psychotic disorders: systematic review. Br J Psychiatry (2008) 1.53

Maternal depression during pregnancy and the postnatal period: risks and possible mechanisms for offspring depression at age 18 years. JAMA Psychiatry (2013) 1.52

Can antiviral therapy for hepatitis C reduce the prevalence of HCV among injecting drug user populations? A modeling analysis of its prevention utility. J Hepatol (2011) 1.50

The timing of middle-childhood peer rejection and friendship: linking early behavior to early-adolescent adjustment. Child Dev (2007) 1.49

Socio-economic position and common mental disorders. Longitudinal study in the general population in the UK. Br J Psychiatry (2006) 1.48

Ethnic differences in prisoners. 1: criminality and psychiatric morbidity. Br J Psychiatry (2002) 1.48

Childhood infection and adult schizophrenia: a meta-analysis of population-based studies. Schizophr Res (2012) 1.46

Cost-effectiveness of cognitive-behavioural therapy as an adjunct to pharmacotherapy for treatment-resistant depression in primary care: economic evaluation of the CoBalT Trial. Br J Psychiatry (2013) 1.44

Risk of schizophrenia and other non-affective psychosis among individuals exposed to head injury: case control study. Schizophr Res (2006) 1.43

Trends in deaths related to drug misuse in England and Wales, 1993-2004. Health Stat Q (2006) 1.43